Chemence Medical Products, Inc. v. James Quinn , 685 F. App'x 701 ( 2017 )


Menu:
  •           Case: 16-16655   Date Filed: 04/12/2017   Page: 1 of 6
    [DO NOT PUBLISH]
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE ELEVENTH CIRCUIT
    ________________________
    No. 16-16655
    ________________________
    D.C. Docket No. 1:11-cv-01366-CAP
    CHEMENCE MEDICAL PRODUCTS, INC.,
    Plaintiff - Counter Defendant - Appellant,
    CHEMENCE, INC.,
    Consol Plaintiff - Counter Defendant - Appellant,
    versus
    JAMES QUINN,
    Defendant - Counter Claimant - Appellee.
    ________________________
    Appeal from the United States District Court
    for the Northern District of Georgia
    ________________________
    (April 12, 2017)
    Case: 16-16655        Date Filed: 04/12/2017       Page: 2 of 6
    Before WILSON and BLACK, Circuit Judges, and RESTANI, * Judge.
    PER CURIAM:
    Chemence, Inc. (Chemence) and Chemence Medical Products, Inc. (CMPI)
    appeal the district court’s denial of their motion for judgment as a matter of law, its
    denial of their motion for a new trial, and certain of its evidentiary rulings in this
    litigation against Dr. James Quinn. After consideration of the parties’ briefs, and
    with the benefit of oral argument, we affirm. 1
    Chemence and CMPI (together, the Chemence Parties) raise seven issues in
    this appeal. First, they contend the district court erred in granting judgment as a
    matter of law because the oral contract between CMPI and Quinn was barred by
    the statute of frauds. Second, they assert the district court erred in excluding the
    testimony of the Chemence Parties’ attorney, Robert Wilson. Third, the Chemence
    Parties argue the district court erred in refusing to grant judgment as a matter of
    law to them on Quinn’s corporate alter ego theory. Fourth and fifth, they submit
    *
    Honorable Jane A. Restani, Judge for the United States Court of International Trade,
    sitting by designation.
    1
    This Court reviews de novo a motion for judgment as a matter of law, and must
    determine whether a reasonable jury would have had a legally sufficient evidentiary basis to find
    for the non-moving party on that issue. Fed. R. Civ. P. 50(a)(1), (b); Abel v. Dubberly, 
    210 F.3d 1334
    , 1337 (11th Cir. 2000). “[T]he court must evaluate all the evidence, together with any
    logical inferences, in the light most favorable to the non-moving party.” McGinnis v. Am. Home
    Mortg. Servicing, Inc., 
    817 F.3d 1241
    , 1254 (11th Cir. 2016) (quotation omitted). The motion
    will be denied if “reasonable minds could reach differing verdicts.” Abel, 
    210 F.3d at 1337
    .
    A district court’s evidentiary rulings are reviewed for an abuse of discretion. Proctor v.
    Fluor Enter., Inc., 
    494 F.3d 1337
    , 1349 n.7 (11th Cir. 2007). Finally, this Court reviews a ruling
    on a motion for a new trial for abuse of discretion. McGinnis, 817 F.3d at 1255.
    2
    Case: 16-16655        Date Filed: 04/12/2017      Page: 3 of 6
    that the district court abused its discretion when it excluded their damages witness
    and permitted Quinn’s damages witness to testify. Sixth, they contend Quinn’s
    future damages were not recoverable under Georgia law and the district court
    should have granted judgment as a matter of law on that basis. Finally, the
    Chemence Parties assert the district court should have granted their motion for a
    new trial on Quinn’s claim that the Chemence Parties acted in bad faith in bringing
    an action against him for violation of the Georgia Trade Secrets Act. 2
    I. DISCUSSION
    A. Statute of Frauds
    The Chemence Parties acknowledge there was an oral agreement with Quinn
    but contend that agreement was unenforceable under Georgia’s statute of frauds.
    See O.C.G.A. § 13-5-30. Their argument consists primarily of two points. First,
    Quinn argued at trial that the oral agreement included the terms of his prior written
    agreement with CMPI. According to the Chemence Parties, some of those terms
    could not have been performed within one year. See id. § 13-5-30(5) (statute of
    frauds applies to “[a]ny agreement that is not to be performed within one year from
    the making thereof”). Second, the Chemence Parties insist Quinn cannot avail
    himself of the part performance exception to the statute of frauds because his
    actions must have been both “consistent with the presence of [the alleged oral]
    2
    We discuss only the first and second issues in this opinion and affirm the remaining
    issues without discussion.
    3
    Case: 16-16655     Date Filed: 04/12/2017   Page: 4 of 6
    contract and inconsistent with the [absence] of [it].” Morgan v. Am. Ins.
    Managers, Inc., 
    521 S.E.2d 676
    , 678 (Ga. Ct. App. 1999) (quotation omitted); see
    O.C.G.A. § 13-5-31(3) (statute of frauds does not apply “[w]here there has been
    such part performance of the contract as would render it a fraud of the party
    refusing to comply if the court did not compel a performance”).
    We need not determine whether the contract could have been performed
    within one year because the evidence was sufficient for a reasonable jury to find
    that Quinn rendered part performance and thus the oral agreement was removed
    from the statute of frauds. It is undisputed that Quinn continued to perform his
    duties, which the Chemence Parties accepted—indeed, they continued paying him
    his $4,000 consulting fee, consistent with the terms of the alleged oral agreement.
    Quinn provided medical and scientific advice, conducted testing to support the
    Chemence Parties’ submissions to the FDA, answered customers’ questions, and
    met with FDA representatives, all after the written agreement had expired. In
    addition, the jury was permitted to credit Quinn’s testimony that when he was
    solicited to perform consulting work for a competitor, he refused and continued to
    put his best efforts into his work for the Chemence Parties because he was entitled
    to commissions. According to Quinn, he notified the Chemence Parties of the
    solicitation immediately and they expressed concern that he would leave. These
    and other facts recounted by the district court show there was sufficient evidence
    4
    Case: 16-16655     Date Filed: 04/12/2017    Page: 5 of 6
    on which a reasonable jury could find the oral contract fell within the part
    performance exception to the statute of frauds. See Hemispherx Biopharma, Inc. v.
    Mid-S. Capital, Inc., 
    690 F.3d 1216
    , 1226–27 (11th Cir. 2012) (“The question of
    whether there has been part performance sufficient to warrant application of this
    exception to the statute of frauds is generally one for the jury.” (citing Hathaway v.
    Bishop, 
    449 S.E.2d 318
    , 320 (Ga. Ct. App. 1994))).
    B. Exclusion of Wilson
    The Chemence Parties also contend the district court erred when it excluded
    Robert Wilson, the Chemence Parties’ general counsel, from serving as a witness
    at trial. Our review of the district court’s decision here is “sharply limited to a
    search for an abuse of discretion and a determination that the findings of the trial
    court are fully supported by the record.” Mee Indus. v. Dow Chem. Co., 
    608 F.3d 1202
    , 1211 (11th Cir. 2010) (quotation omitted). We find no such abuse of
    discretion. The district court accurately assessed the history of the case, including
    the Chemence Parties’ multiple representations to the court that Wilson would not
    serve as a witness, resulting in the court’s permitting him to continue as litigation
    counsel over Quinn’s objection. As a result, Wilson participated in all subsequent
    discovery in the case. The district court was within its discretion to grant Quinn’s
    motion to exclude Wilson as a witness.
    5
    Case: 16-16655    Date Filed: 04/12/2017    Page: 6 of 6
    II. CONCLUSION
    For the foregoing reasons, the judgment of the district court is
    AFFIRMED.
    6
    

Document Info

Docket Number: 16-16655

Citation Numbers: 685 F. App'x 701

Judges: Wilson, Black, Restani

Filed Date: 4/12/2017

Precedential Status: Non-Precedential

Modified Date: 10/19/2024